Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02019927
Other study ID # 12-232
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2013
Est. completion date September 2017

Study information

Verified date January 2020
Source Wills Eye
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Transcorneal Electrical Stimulation (TES) using the "OkuStim®" device delivers electrical impulses to damaged and/or diseased photoreceptor cells. This electric stimulation of the retina may help to preserve visual acuity and/or the visual field.


Description:

The finely detailed, precise anatomy of the retina and optic nerve capture light impulses from the environment through a biochemical process and then transmit these images to the brain via electrical impulses conducted from the inner retina to the optic nerve and ultimately to the occipital cortex.

In the human eye, three types of specialized ganglion cells transmit electrical impulses to the brain. Among these three cell populations are rod and cone cells, which participate in the photo-transduction step of light perception, along with other light sensitive ganglion cells. It is a system whereby the photosensitive pigment rhodopsin (or one of its analogs) rearranges in response to light, and this change in chemical structure fires electrical impulses to the brain which in turn interprets the incoming impulses as a visual image.

Transcorneal Electrical Stimulation (TES) using the "OkuStimĀ®" device delivers electrical impulses to damaged and/or diseased photoreceptor cells. This electric stimulation of the retina may help to preserve VA and/or the visual field.


Recruitment information / eligibility

Status Completed
Enrollment 97
Est. completion date September 2017
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- You are 18 years or older.

- You have sustained trauma (more than 3 months before this study) OR been diagnosed with Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) (more than 6 months before this study) OR been diagnosed with Multiple Sclerosis (MS) and suffered visual loss (more than 3 months before this study).

- You are willing and able to give written informed consent.

- You are able to commit to enrolling in the study during the full time period of up to 6 months.

Exclusion Criteria:

- You have any other significant ophthalmologic disease or condition (such as glaucoma, retinal degeneration, proliferative diabetic retinopathy, +/- six diopters of myopia, retinal detachment, exudative age-related macular degeneration).

- You have amblyopia (lazy eye) in affected eye, previously diagnosed.

- You are participating in any other interventional clinical trial.

- If you are pregnant OR a woman with childbearing potential who is unwilling to use medically acceptable means of birth control for study duration OR woman unwilling to perform a pregnancy test at study entry/screening.

- You are unable to give signed consent due to memory, medical, communication, language, or mental health problems.

- You are less than 18 years old.

- You are unable or unwilling to complete the evaluation or questionnaire.

- Visual acuity better than 20/40

- Inability to detect phosphenes during threshold detection

- You are on seizure medications, or have a history of epilepsy.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcorneal Electrical Stimulation
The clinical trial will investigate whether Transcorneal Electrical Stimulation delivered by the Okuvision Stimulation Set manufactured by Okuvision GmbH, Reutlingen, Germany, is a potentially effective therapy for the restoration and rehabilitation of vision loss as measured by improvements in visual acuity in the following three patient populations: patients with ocular trauma, patients with optic neuritis associated with multiple sclerosis and patients with Non-arteritic Anterior Ischemic Optic Neuropathy.
Sham
Sham

Locations

Country Name City State
United States Wills Eye Hospital Philadelphia Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Wills Eye United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the Effectiveness and Safety of Transcorneal Electrical Stimulation to Improve Visual Acuity The primary outcomes are change in high-contrast LogMar VA from baseline (week 1) to initial post treatment (week 8). Participants read letters from a chart and receive 1 point for each letter correctly identified. Scores are converted to logMAR scale and analyzed for changes in visual acuity. Improvement in visual acuity is defined as a decrease in logMAR of 0.2 or more. Change from Baseline (week 1) to 1-week post initial treatment (week 8)
Secondary Intra-Ocular Pressure (IOP) Measured by Applanation (Galdmann) Tonometry method Change from Baseline (week 1) to 1-week post initial treatment (week 8)
Secondary Visual Field Mean Deviation The Humphrey 24-2 Swedish Interactive Threshold Algorithm Standard perimeter was used to test visual field. Reported values are a change from baseline to 1-week post initial treatment. Change from Baseline (week 1) to 1 - week post initial treatment (week 8)
Secondary Ocular Coherent Tomography, Retinal Nerve Fiber Layer Thickness in Superior Quadrant Assessed the change in thickness of the retinal nerve fiber layer 1-week post treatment compared to baseline Change from Baseline (week 1) to 1 - week post initial treatment (week 8)
Secondary Ocular Coherent Tomography, Retinal Nerve Fiber Layer Thickness in Nasal Quadrant Assessed the change in thickness of the retinal nerve fiber layer 1-week post treatment compared to baseline Change from Baseline (week 1) to 1 - week post initial treatment (week 8)
Secondary Ocular Coherent Tomography, Retinal Nerve Fiber Layer Thickness in Inferior Quadrant Assessed the change in thickness of the retinal nerve fiber layer 1-week post treatment compared to baseline Change from Baseline (week 1) to 1 - week post initial treatment (week 8)
Secondary Ocular Coherent Tomography, Retinal Nerve Fiber Layer Thickness in Temporal Quadrant Assessed the change in thickness of the retinal nerve fiber layer 1-week post treatment compared to baseline Change from Baseline (week 1) to 1 - week post initial treatment (week 8)
Secondary Ocular Coherent Tomography, Retinal Nerve Fiber Layer Thickness in Center Quadrant Assessed the change in thickness of the retinal nerve fiber layer 1-week post treatment compared to baseline Change from Baseline (week 1) to 1 - week post initial treatment (week 8)
Secondary National Eye Institute's Visual Functioning Questionnaire - 25 Test to measure Unweighted of scores within test ranging from 0-100 with higher scores meaning better outcome Change from Baseline to 1 - week post initial treatment
Secondary Symbol Digit Modality Testing Scores range from 0-110 with higher scores meaning better visual information processing speed Change from Baseline to 1 - week post initial treatment
See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Terminated NCT03781817 - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures Phase 4
Completed NCT04342416 - Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women N/A
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT05669313 - The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Recruiting NCT04725721 - Testing FIRST in Youth Outpatient Psychotherapy N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Not yet recruiting NCT03696563 - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS N/A
Withdrawn NCT03249129 - Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
Completed NCT02240732 - Surgical Tourniquets and Cerebral Emboli N/A
Completed NCT02227979 - Effects of PURPLE Cry Intervention N/A
Withdrawn NCT01169025 - Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients N/A
Recruiting NCT01812941 - Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients N/A
Completed NCT01475344 - Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC) Phase 1/Phase 2
Completed NCT03112304 - Child STEPS for Youth Mental Health in Maine Sustainability N/A
Completed NCT01201863 - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Phase 4
Completed NCT01210417 - Trauma Heart to Arm Time N/A